Smith J. Jefferson's Form 4 filing
Precision Biosciences Inc (DTIL) · filed Jun 11, 2024
- Accession no.
- 0000950170-24-072049
- Filed
- Jun 11, 2024
- Trade date
- Jun 7-10, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $589.5. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith J. JeffersonCIK 0001770169 | Officer (Chief Research Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Common Stock | MOption exerciseAcquired | +163 | – | – | 68,609 | Direct | |
| Jun 10, 2024 | Common Stock | SSaleDisposed | −50 | $11.79 | −$589.5 | 68,559 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 | Common Stock | MOption exerciseDisposed | −163 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.